AGTC to Present at Upcoming Conferences GAINESVILLE,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
AGTC to Present at Upcoming Conferences

GAINESVILLE, Fla., and CAMBRIDGE, Mass., Dec. 05, 2016 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ: AGTC ), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced its participation in upcoming conferences.

  • Genetic Rx — Boston, Mass. (December 8, 2016) AGTC President & CEO Sue Washer will be moderating a panel discussion entitled “Manufacturing and Commercialization: Strategies for Success” from 11:45am – 12:15pm ET. The event will take place at Harvard Medical School and will bring together academics, key industry leaders and investors to discuss the emergence of new genetic medicines as well as the treatment of patients with rare genetic diseases.
  • BMO Capital Markets Prescriptions for Success Healthcare Conference – New York, N.Y. (December 14, 2016) Sue Washer will provide a company presentation at 3:20pm ET. Ms. Washer will discuss key corporate milestones in addition to reviewing AGTC's clinical pipeline. A live audio webcast of the presentation can be accessible by visiting ir.agtc.com/events.cfm . A replay will be available on the company’s website following the event.

About AGTC

AGTC is a clinical-stage biotechnology company that uses its proprietary gene therapy platform to develop products designed to transform the lives of patients with severe diseases, with an initial focus in ophthalmology. AGTC's lead product candidates are designed to treat inherited orphan diseases of the eye, caused by mutations in single genes that significantly affect visual function and currently lack effective medical treatments.

AGTC's product pipeline includes six named ophthalmology development programs across five targets (X-linked retinoschisis (XLRS), X-linked retinitis pigmentosa (XLRP), achromatopsia, wet age-related macular degeneration and blue cone monochromacy), two non-ophthalmology programs (alpha-1 antitrypsin deficiency and adrenoleukodystrophy) and AGTC is continuing to develop early research studies in additional indications. The company is also exploring genetic defects in cells in the inner ear that lead to deafness and expects to advance several product candidates into development within the next few years. AGTC employs a highly targeted approach to selecting and designing its product candidates, choosing to develop therapies for indications having high unmet medical need, clinical feasibility and commercial potential. AGTC has a significant intellectual property portfolio and extensive expertise in the design of gene therapy products including capsids, promoters and expression cassettes, as well as, expertise in the formulation, manufacture and physical delivery of gene therapy products.

IR/PR CONTACTS: David Carey (IR) or Danielle Lewis (PR) Lazar Partners Ltd. T: (212) 867-1768 or (212) 843-0211 dcarey@lazarpartners.com or dlewis@lazarpartners.com Corporate Contacts: Larry Bullock Chief Financial Officer Applied Genetic Technologies Corporation T: (386) 462-2204      lbullock@agtc.com Stephen Potter Chief Business Officer Applied Genetic Technologies Corporation T: (617) 413-2754 spotter@agtc.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sacrifice Unending: 9/11's Lingering Health Toll

Updated Category News Views 1

The Unseen Toll of 9/11 on the Firefighter Community Two and a half decades since that fateful morning of September 11, 2001, we're staring at a grim reality. The heroic souls of the New York City Fire Department (FDNY)—those who ran toward peril when others ran away—are still paying the price. Incredibly, more than 400 FDNY members have succumbed to World Trade...

Continue Reading
Fresh Thyme Empowers Local Brands in Michigan Debut

Updated Category News Views 2

A Community-Driven Retail Innovation The grocery game just got a little more personal in Michigan, and we're not talking about run-of-the-mill retail pitches. Fresh Thyme Market, known for its commitment to local and natural products, is shaking things up with their Pitch Thyme Competition. This ain’t your usual product presentation. It’s a whole new ball game where...

Continue Reading
ABC Honors 2026 Spirit of the Heart Leaders

Updated Category News Views 4

Celebrating Champions of Cardiovascular Health In a world where accolades often feel as cold as the stock market after a crash, it’s heartening to see genuine recognition for those who are making actual, lasting impact. On October 3, 2026, the Association of Black Cardiologists (ABC) will hold its annual Spirit of the Heart Awards at none other than Cipriani Wall...

Continue Reading
ZEEKR's Shooting Brakes Dominate: Over 400K Sold

Updated Category News Views 3

ZEEKR's Stellar Performance in a Crowded Market Another month, another bumper crop for ZEEKR's shooting brakes. These beauties aren't just hanging in there; they're leading the pack. In August alone, global deliveries marched past the 10,000 mark for the third month running—a feat not easily achieved in today's saturated automotive landscape. It's no wonder the...

Continue Reading
Global Communication Works Opens SignlLabs™ AI Licensing

Updated Category News Views 42

AI Signaling Moves Beyond GCW's Own Clients Remember when we first looked at GCW's SignlLabs and the idea of helping brands show up inside ChatGPT, Gemini, Claude, Copilot and Perplexity? Well, Global Communication Works is taking the next step. Instead of keeping its AI Signaling playbook inside the agency walls, GCW is now opening SignlLabs up for licensing

Continue Reading
Are FULC, WEAV, TECH Shareholders Getting a Raw Deal?

Updated Category News Views 3

Pocketing Insider Gains Amidst Shareholder Concerns Let me tell you, it smells like another day in the financial jungle where insiders might be feasting while the regular Joe shareholders are left nibbling on crumbs. Fulcrum Therapeutics, Weave Communications, and Bio-Techne are in the crosshairs for deals that may favor those on the inside track over you and me, the...

Continue Reading
South Florida Donor Network Honors 52 Heroic Donors

Updated Category News Views 4

A Heartfelt Tribute to Lifesavers You ever been to a gathering that reminds you how deeply human connections run? That's what happened at The Diplomat Beach Resort in Hollywood. South Florida Donor Network (SFDN) pulled together a ceremony honoring 52 donor heroes whose legacies beat strong through the recipients living thanks to their gifts. An Event Worth Attending...

Continue Reading
Push Notification Security Transforms Healthcare IT Support

Updated Category News Views 2

Cutting the Fat on IT Help Desk Bottlenecks Healthcare IT teams are fighting an uphill battle with password resets, a mundane task consuming up to half of all help desk calls. It's like trying to stop a leaking dam with duct tape. For health systems, these calls aren't just a minor annoyance—they're a full-fledged budget hog. Try telling a CIO that an agent-friendly...

Continue Reading
Woodpack Global Unveils Crate Design System: A New Era Begins

Updated Category News Views 2

Innovating the Wooden Crate Landscape An old industry got a much-needed facelift today, folks. Woodpack Global has rolled out Crate Design System™ (CDS)—a snazzy new tool that's shaking up the wooden crate design landscape. It blows the dust off outdated design methods that have been collecting cobwebs since the '60s. That's right, we’re talking about a significant...

Continue Reading
Sandbox VR Expands to Melbourne, Betting on Immersive Fun

Updated Category News Views 1

Sandbox VR Ventures into Melbourne's Heart Every now and then, a venture takes its ambitions and rolls the dice on a prime location. Sandbox VR is swaggering into Melbourne's bustling Central Business District, fresh out of its success on the Gold Coast. Opening this Melbourne venue on September 14 marks a significant leap in the company's Aussie expansion—a bold nod to...

Continue Reading

Top 5 Most Recently Viewed Articles

Russell Investments Canada Limited Reveals ETF Monthly Payouts

Updated Category News Views 159

Russell Investments Canada Limited Announces Cash Distributions Russell Investments Canada Limited today unveiled the cash distributions for the ETF Series of selected mutual funds for December 2024. The unitholders recorded as of the specified Record Date will receive the announced cash distribution per unit on the established Payment Date. Details of the ETF...

Continue Reading
EBANX Takes Significant Steps in Global Digital Payment Expansion

Updated Category News Views 150

EBANX Enhances Global Payment Operations EBANX, a renowned global Payment Service Provider (PSP) dedicated to emerging markets, has achieved a pivotal milestone by securing In-Principle Approval for a Major Payment Institution (MPI) license from the Monetary Authority of Singapore. This crucial approval not only bolsters EBANX's operational framework within the...

Continue Reading
Arcadis Q3 2024 Update: Major Wins Fuel Growth and Margins

Updated Category News Views 102

Arcadis Q3 2024 Update Highlights Arcadis has released its trading update for the third quarter of 2024, showcasing impressive growth driven by significant project wins and solid revenue generation. Key Financial Performance Metrics This quarter proved to be transformative for Arcadis, with a notable order intake of €1.3 billion, representing a remarkable 50%...

Continue Reading
FS8 Expands its Reach with New Studios and Community Focus

Updated Category News Views 264

FS8 Expands its Reach with New Studios and Community Focus With recent studio openings and a vibrant brand campaign, FS8 is dedicated to growing its presence and creating community connections. This expansion is aimed at introducing more individuals to their innovative fitness classes combining Pilates, Tone, and Yoga. As FS8 continues to flourish, it's laying down a...

Continue Reading
BIO-key International to Join H.C. Wainwright Conference

Updated Category News Views 119

BIO-key International to Participate in H.C. Wainwright Conference BIO-key International, Inc. (NASDAQ: BKYI), a leading provider of innovative Identity and Access Management (IAM) software for both workforce and customer applications, is set to take part in H.C. Wainwright’s 26th Annual Hybrid Global Investment Conference. This event will take place on September 9th...

Continue Reading